Functional Analysis of Tcl1 Using Tcl1-Deficient Mouse Embryonic Stem Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Miyazaki, Tatsushi ^a   Miyazaki, Satsuki ^a   Ashida, Masafumi ^a   Tanaka, Tomofumi ^a   Tashiro, Fumi ^a   Miyazaki, Jun ichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL DNA; PROTEIN KINASE B; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOUSE; NDP52 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN DEFICIENCY; PROTEIN STABILITY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; T CELL LYMPHOMA BREAKPOINT 1 GENE; WILD TYPE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE TRANSFER TECHNIQUES; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS; WNT SIGNALING PATHWAY;

EID: 84881118668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071645     Document Type: Article

References (44)

1. Eckfeldt CE, Mendenhall EM, Verfaillie CM, (2005) The molecular repertoire of the 'almighty' stem cell. Nat Rev Mol Cell Biol 6: 726-737.
2. Narducci MG, Fiorenza MT, Kang S-M, Bevilacqua A, Giacomo MD, et al. (2002) TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc Natl Acad Sci USA 99: 11712-11717.
3. Narducci MG, Virgilio L, Engiles JB, Buchberg AM, Billips L, et al. (1997) The murine Tcl1 oncogene: embryonic and lymphoid cell expression. Oncogene 15: 919-926.
4. Kang S-M, Narducci MG, Lazzeri C, Mongiovì AM, Caprini E, et al. (2005) Impaired T- and B-cell development in Tcl1-deficient mice. Blood 105: 1288-1294.
5. Hallas C, Pekarsky Y, Itoyama T, Varnum J, Bichi R, (1999) Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes. Proc Natl Acad Sci USA 96: 14418-14423.
6. Teitell MA, (2005) The TCL1 family of oncoproteins: co-activators of transformation. Nat Rev Cancer 5: 640-648.
7. Virgilio L, Lazzeri C, Bichi R, Nibu K, Narducci MG, et al. (1998) Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci USA 95: 3885-3889.
8. Glover CH, Marin M, Eaves CJ, Helgason CD, Piret JM, et al. (2006) Meta-analysis of differentiating mouse embryonic stem cell gene expression kinetics reveals early change of a small gene set. Plos Comput Biol 2: e158.
9. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, et al. (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473: 398-402.
10. Jang H, Kim TW, Yoon S, Choi SY, Kang TW, et al. (2012) O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 11: 62-74.
11. Matoba R, Niwa H, Masui S, Ohtsuka S, Carter MG, et al. (2006) Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PloS One 1: e26.
12. Niwa H, Miyazaki J, Smith AG, (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376.
13. Ambrosetti DC, Schöler HR, Dailey L, Basilico C, (2000) Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J Biol Chem 275: 23387-23397.
14. Cervantes RB, Stringer JR, Shao C, Tischfield JA, Stambrook PJ, (2002) Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 99: 3586-3590.
15. Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, et al. (2000) Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 97: 3028-3033.
16. Song G, Ouyang G, Bao S, (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59-71.
17. Chan TO, Rittenhouse SE, Tsichlis PN, (1999) AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 68: 965-1014.
18. Wang J, Wynshaw-Boris A, (2004) The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation. Curr Opin Genet Dev 14: 533-539.
19. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH, (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55-63.
20. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, et al. (2005) LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896.
21. Tian Q, Feetham MC, Tao WA, He XC, Li L, (2004) Proteomic analysis identifies that 14-3-3ζ interacts with beta-catenin and facilitates its activation by Akt. Proc Natl Acad Sci USA 101: 15370-15375.
22. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, et al. (2003) Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 100: 4610-4615.
23. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. (1997) Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
24. Lickert H, Cox B, Wehrle C, Taketo MM, Kemler R, et al. (2005) Dissecting Wnt/β-catenin signaling during gastrulation using RNA interference in mouse embryos. Development 132: 2599-2609.
25. Laine J, Künstle G, Obata T, Noguchi M, (2002) Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. J Biol Chem 277: 3743-3751.
26. Paling NRD, Wheadon H, Bone HK, Welham MJ, (2004) Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 279: 48063-48070.
27. Hallmann D, Trümper K, Trusheim H, Ueki K, Kahn CR, et al. (2003) Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85α. J Biol Chem 278: 5099-5108.
28. Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P, (2002) Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21: 5515-5528.
29. Stiles B, Gilman V, Khanzenzon N, Lesche R, Li A, et al. (2002) Essential role of AKT-1/Protein kinase Bα in PTEN-controlled tumorigenesis. Mol Cell Biol 22: 3842-3851.
30. Ema M, Mori D, Niwa H, Hasegawa Y, Yamanaka Y, (2008) Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3: 555-567.
31. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D, (2003) TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 101: 5007-5009.
32. Niwa H, (2011) Wnt: what's needed to maintain pluripotency? Nat Cell Biol 13: 1024-1026.
33. Sokol SY, (2011) Maintaining embryonic stem cell pluripotency with Wnt Signaling. Development 138: 4341-4350.
34. Wray J, Hartmann C, (2012) WNTing embryonic stem cells. Trends Cell Biol. 22: 159-168.
35. Kemler R, Hierholzer A, Kanzler B, Kuppig S, Hansen K, et al. (2004) Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast. Development 131: 5817-5824.
36. Huelsken J, Vogel R, Brinkmann V, Erdmann B, Birchmeier C, et al. (2000) Requirement for β-catenin in anterior-posterior axis formation in mice. J Cell Biol 148: 567-578.
37. Morkel M, Huelsken J, Wakamiya M, Ding J, van de Wetering M, et al. (2003) β-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 130: 6283-6294.
38. Najm FJ, Chenoweth JG, Anderson PD, Nadeau JH, Redline RW, et al. (2011) Isolation of epiblast stem cells from pre-implantation mouse embryos. Cell Stem Cell 8: 318-325.
39. Hayashi K, Lopes SM, Tang F, Surani MA, (2008) Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3: 391-401.
40. Moritoh Y, Yamato E, Yasui Y, Miyazaki S, Miyazaki J, (2003) Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 52: 1163-1168.
41. Yanagawa Y, Kobayashi T, Ohnishi M, Kobayashi T, Tamura S, et al. (1999) Enrichment and efficient screening of ES cells containing a targeted mutation: the use of DT-A gene with the polyadenylation signal as a negative selection maker. Transgenic Res 8: 215-221.
42. Niwa H, Burdon T, Chambers I, Smith A, (1998) Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12: 2048-2060.
43. Sauer B, (1993) Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol 225: 890-900.
44. Fujikura J, Yamato E, Yonemura S, Hosoda K, Masui S, et al. (2002) Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev 16: 784-789.